Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort

被引:7
作者
Chew, Christine [1 ]
Reynolds, John A. [2 ,3 ]
Lertratanakul, Apinya [4 ]
Wu, Peggy [4 ]
Urowitz, Murray [5 ]
Gladman, Dafna D. [5 ]
Fortin, Paul R. [6 ]
Bae, Sang-Cheol [7 ]
Gordon, Caroline [3 ]
Clarke, Ann E. [8 ,9 ]
Bernatsky, Sasha [10 ]
Hanly, John G. [11 ,12 ]
Isenberg, David [13 ]
Rahman, Anisur [13 ]
Sanchez-Guerrero, Jorge [5 ]
Romero-Diaz, Juanita [14 ]
Merrill, Joan [15 ]
Wallace, Daniel [16 ]
Ginzler, Ellen [17 ]
Khamashta, Munther [18 ]
Nived, Ola [19 ]
Jonsen, Andreas [19 ]
Steinsson, Kristjan [20 ]
Manzi, Susan [21 ]
Kalunian, Ken [22 ]
Dooley, Mary Anne [23 ]
Petri, Michelle [24 ]
Aranow, Cynthia [25 ]
van Vollenhoven, Ronald [26 ]
Stoll, Thomas [27 ]
Alarcon, Graciela S. [28 ]
Lim, S. Sam [29 ]
Ruiz-Irastorza, Guillermo [30 ]
Peschken, Christine A. [31 ]
Askanase, Anca D. [32 ]
Kamen, Diane L. [33 ]
Inanc, Murat [34 ]
Ramsey-Goldman, Rosalind [4 ]
Bruce, Ian N. [35 ,36 ]
机构
[1] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth,Lydia Becker Inst Immunol & I, Manchester Collaborat Ctr Inflammat Res, Manchester, Lancs, England
[2] Sandwell & West Birmingham NHS Trust, Dept Rheumatol, Birmingham, W Midlands, England
[3] Univ Birmingham, Inst Inflammat & Ageing, Rheumatol Res Grp, Birmingham, W Midlands, England
[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[5] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada
[6] Univ Laval, Dept Rheumatol, Fac Med, Quebec City, PQ, Canada
[7] Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul, South Korea
[8] Univ Calgary, Div Clin Immunol Allergy, Cumming Sch Med, Calgary, AB, Canada
[9] Univ Calgary, Div Clin Epidemiol, Cumming Sch Med, Calgary, AB, Canada
[10] McGill Univ, Fac Med, Div Rheumatol, Montreal, PQ, Canada
[11] Queen Elizabeth 2 Hlth Sci Ctr, Dept Med, Div Rheumatol, Halifax, NS, Canada
[12] Queen Elizabeth 2 Hlth Sci Ctr, Dept Pathol Halifax, Halifax, NS, Canada
[13] UCL, Fac Med Sci, Div Med, London, England
[14] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Immunol & Rheumatol Tlalpan, Mexico City, DF, Mexico
[15] Oklahoma Med Res Fdn, Dept Clin Pharmacol, Arthrit & Clin Immunol Res Program, Oklahoma City, OK USA
[16] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai, Cedars Sinai Med Ctr, Los Angeles, CA 90095 USA
[17] SUNY Downstate Med Ctr Coll Med, Dept Med, Brooklyn, NY USA
[18] Kings Coll London, Rayne Inst, St Thomas Hosp, Sch Med, London, England
[19] Lund Univ, Fac Med, Dept Clin Sci Lund, Sect Rheumatol, Lund, Sweden
[20] Natl Univ Hosp Iceland, Dept Rheumatol, Reykjavik, Iceland
[21] Lupus Ctr Excellence, Allegheny Hlth Network, Pittsburgh, PA USA
[22] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA
[23] Univ N Carolina, Div Rheumatol & Immunol, Dept Med, Chapel Hill, NC USA
[24] Johns Hopkins Univ, Sch Med, Ctr Musculoskeletal Res, Dept Rheumatol, Baltimore, MD USA
[25] Northwell Hlth Feinstein Inst Med Res, Manhasset, NY USA
[26] Amsterdam Univ Med Ctr, Duivendrecht, Noord Holland, Netherlands
[27] Kantonsspital Schaffhausen, Dept Rheumatol, Schaffhausen, Schaffhausen, Switzerland
[28] Univ Alabama Birmingham, Sch Med, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL USA
[29] Emory Univ, Div Rheumatol, Sch Med, Atlanta, GA USA
[30] Hosp Univ Cruces, Biocruces Bizkaia Hlth Res Inst, Autoimmune Dis Units, Baracaldo, Pais Vasco, Spain
[31] Univ Manitoba, Winnipeg, MB, Canada
[32] Columbia Univ, Irving Med Ctr, New York, NY USA
[33] Med Univ South Carolina, Charleston, SC 29425 USA
[34] Istanbul Univ Istanbul, Fac Med, Dept Internal Med, Div Rheumatol, Istanbul, Turkey
[35] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Kellgren Ctr Rheumatol, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England
[36] Univ Manchester, Fac Biol Med & Hlth, Versus Arthrit Ctr Epidemiol, Div Musculoskeletal & Dermatol Sci, Oxford Rd, Manchester M13 9PT, Lancs, England
基金
加拿大健康研究院;
关键词
systemic lupus erythematosus; vitamin D; cardiovascular disease; epidemiology; 25-HYDROXYVITAMIN D DEFICIENCY; CARDIOVASCULAR RISK-FACTORS; LOW-DENSITY-LIPOPROTEIN; 3RD NATIONAL-HEALTH; ERYTHEMATOSUS DATA; DISEASE-ACTIVITY; INDEPENDENT ASSOCIATION; WOMEN; PREVALENCE; 1,25-DIHYDROXYVITAMIN-D;
D O I
10.1093/rheumatology/keab090
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. Vitamin D (25(OH)D) deficiency and metabolic syndrome (MetS) may both contribute to increased cardiovascular risk in SLE. We aimed to examine the association of demographic factors, SLE phenotype, therapy and vitamin D levels with MetS and insulin resistance. Methods. The Systemic Lupus International Collaborating Clinics (SLICC) enrolled patients recently diagnosed with SLE (<15 months) from 33 centres across 11 countries from 2000. Clinical, laboratory and therapeutic data were collected. Vitamin D level was defined according to tertiles based on distribution across this cohort, which were set at T1 (10-36 nmol/l), T2 (37-60 nmol/l) and T3 (61-174 nmol/l). MetS was defined according to the 2009 consensus statement from the International Diabetes Federation. Insulin resistance was determined using the HOMA-IR model. Linear and logistic regressions were used to assess the association of variables with vitamin D levels. Results. Of the 1847 patients, 1163 (63%) had vitamin D measured and 398 (34.2%) subjects were in the lowest 25(OH)D tertile. MetS was present in 286 of 860 (33%) patients whose status could be determined. Patients with lower 25(OH)D were more likely to have MetS and higher HOMA-IR. The MetS components, hypertension, hypertriglyceridemia and decreased high-density lipoprotein (HDL) were all significantly associated with lower 25(OH)D. Increased average glucocorticoid exposure was associated with higher insulin resistance. Conclusions. MetS and insulin resistance are associated with lower vitamin D in patients with SLE. Further studies could determine whether vitamin D repletion confers better control of these cardiovascular risk factors and improve long-term outcomes in SLE.
引用
收藏
页码:4737 / 4747
页数:11
相关论文
共 48 条
[1]   Control of autoimmune diseases by the vitamin D endocrine system [J].
Adorini, Luciano ;
Penna, Giuseppe .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (08) :404-412
[2]  
Akin F, 2012, J INVEST MED, V60, P869, DOI 10.2310/JIM.0b013e31825457cb
[3]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[4]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[5]   Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? [J].
Amital, H. ;
Szekanecz, Z. ;
Szucs, G. ;
Danko, K. ;
Nagy, E. ;
Csepany, T. ;
Kiss, E. ;
Rovensky, J. ;
Tuchynova, A. ;
Kozakova, D. ;
Doria, A. ;
Corocher, N. ;
Agmon-Levin, N. ;
Barak, V. ;
Orbach, H. ;
Zandman-Goddard, G. ;
Shoenfeld, Y. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) :1155-1157
[6]   Metabolic syndrome in Argentinean patients with systemic lupus erythematosus [J].
Bellomio, V. ;
Spindler, A. ;
Lucero, E. ;
Berman, A. ;
Sueldo, R. ;
Berman, H. ;
Santana, M. ;
Molina, M. J. ;
Gongora, V. ;
Cassano, G. ;
Paira, S. ;
Saurit, V. ;
Retamozo, G. ;
Alvarellos, A. ;
Caerio, F. ;
Alba, P. ;
Gotero, M. ;
Velozo, E. J. ;
Ceballos, F. ;
Soriano, E. ;
Catoggio, L. ;
Garcia, M. A. ;
Eimon, A. ;
Agueero, S. .
LUPUS, 2009, 18 (11) :1019-1025
[7]   Premature atherosclerosis in systemic lupus erythematosus [J].
Bruce, IN ;
Gladman, DD ;
Urowitz, MB .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2000, 26 (02) :257-+
[8]   Treatment of vitamin D deficiency with UV light in patients with malabsorption syndromes: A case series [J].
Chandra, Prakash ;
Wolfenden, Linda L. ;
Ziegler, Thomas R. ;
Tian, Junqiang ;
Luo, Menghua ;
Stecenko, Arlene A. ;
Chen, Tai C. ;
Holick, Michael F. ;
Tangpricha, Vin .
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2007, 23 (05) :179-185
[9]   Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls [J].
Chang, Yu-mei ;
Barrett, Jennifer H. ;
Bishop, D. Timothy ;
Armstrong, Bruce K. ;
Bataille, Veronique ;
Bergman, Wilma ;
Berwick, Marianne ;
Bracci, Paige M. ;
Elwood, J. Mark ;
Ernstoff, Marc S. ;
Gallagher, Richard P. ;
Green, Adele C. ;
Gruis, Nelleke A. ;
Holly, Elizabeth A. ;
Ingvar, Christian ;
Kanetsky, Peter A. ;
Karagas, Margaret R. ;
Lee, Tim K. ;
Le Marchand, Loic ;
Mackie, Rona M. ;
Olsson, Hakan ;
Osterlind, Anne ;
Rebbeck, Timothy R. ;
Sasieni, Peter ;
Siskind, Victor ;
Swerdlow, Anthony J. ;
Titus-Ernstoff, Linda ;
Zens, Michael S. ;
Newton-Bishop, Julia A. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2009, 38 (03) :814-830
[10]   High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors [J].
Chung, Cecilia P. ;
Avalos, Ingrid ;
Oeser, Annette ;
Gebretsadik, Tebeb ;
Shintani, Ayumi ;
Raggi, Paolo ;
Stein, C. Michael .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) :208-214